09/04/2024 6:40 AM | Shalev Varda (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/14/2024 6:06 AM | Daniell Richard (Reporting) Teva Pharmaceutical Industries (Subject)
| Form 144/A | |
08/14/2024 5:24 AM | Hughes Eric A (Reporting) Teva Pharmaceutical Industries (Subject)
| Form 144/A | |
08/12/2024 3:09 PM | Daniell Richard (Reporting) Teva Pharmaceutical Industries (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/05/2024 6:32 AM | Jover Placid (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/05/2024 6:35 AM | Hughes Eric A (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/05/2024 6:30 AM | Jover Placid (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
|
07/31/2024 3:06 PM | Teva Pharmaceutical Industries (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/31/2024 6:00 AM | Teva Pharmaceutical Industries (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/25/2024 7:01 AM | Teva Pharmaceutical Industries (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/17/2024 7:00 AM | MIGNONE ROBERTO (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/17/2024 7:03 AM | Teva Pharmaceutical Industries (Issuer) Zaks Tal Zvi (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/17/2024 6:38 AM | Satchi-Fainaro Ronit (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/17/2024 6:41 AM | Crane Rosemary A (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/17/2024 6:23 AM | Teva Pharmaceutical Industries (Issuer) Vergis Janet S. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/17/2024 6:27 AM | Nisen Perry (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/17/2024 6:14 AM | BARER SOL J (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/17/2024 6:17 AM | Elstein Amir (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/17/2024 6:20 AM | LIEBERMAN GERALD M (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/10/2024 6:45 AM | MIGNONE ROBERTO (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/10/2024 6:47 AM | Satchi-Fainaro Ronit (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/10/2024 6:49 AM | Crane Rosemary A (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/10/2024 6:51 AM | Teva Pharmaceutical Industries (Issuer) Zaks Tal Zvi (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/10/2024 6:53 AM | Shalev Varda (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/10/2024 6:36 AM | Teva Pharmaceutical Industries (Issuer) Vergis Janet S. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/10/2024 6:38 AM | LIEBERMAN GERALD M (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/10/2024 6:42 AM | Nisen Perry (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/10/2024 6:31 AM | BARER SOL J (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/10/2024 6:33 AM | Elstein Amir (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2024 6:25 AM | Shields Matthew (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2024 6:18 AM | Shields Matthew (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
05/17/2024 6:41 AM | Teva Pharmaceutical Industries (Issuer) Weiss Amir (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/15/2024 7:30 AM | Teva Pharmaceutical Industries (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/15/2024 7:36 AM | Conway Vikki L (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/08/2024 6:01 AM | Teva Pharmaceutical Industries (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/16/2024 3:12 PM | Teva Pharmaceutical Industries (Filer)
| Form ARS | |
04/16/2024 3:16 PM | Teva Pharmaceutical Industries (Filer)
| Form DEFA14A | |
04/09/2024 9:26 AM | Phoenix Holdings Ltd. (Filed by) Teva Pharmaceutical Industries (Subject)
| Form SC 13G/A | |
03/07/2024 3:27 PM | Kalif Eliyahu Sharon (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 3:27 PM | Francis Richard D (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/01/2024 5:57 AM | Bergwerk Dov (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
Biden's Successor: The Radical Threat to YOUR Savings! (Ad) Kamala Harris isn't just playing politics; she's a serious threat to your financial security.
Kamala has a plan to take over your money and leave you with nothing. Higher taxes, government control, and a digital dollar to track every penny you spend. This isn't about convenience; it's about CONTROL.![](https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=9457&Placement=NativeDisplay&Source=NativeDisplay) >> Get Your FREE Wealth Protection Guide << |
03/01/2024 5:48 AM | Teva Pharmaceutical Industries (Issuer) Weiss Amir (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/01/2024 5:52 AM | Sabag Mark (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/01/2024 5:54 AM | Kalif Eliyahu Sharon (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/01/2024 5:40 AM | Conway Vikki L (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/01/2024 5:43 AM | Daniell Richard (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/01/2024 5:45 AM | Drape Eric (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2024 6:37 AM | Drape Eric (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/20/2024 6:42 AM | Francis Richard D (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 6:37 AM | Kalif Eliyahu Sharon (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2024 6:01 AM | Teva Pharmaceutical Industries (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/05/2024 6:49 AM | Teva Pharmaceutical Industries (Issuer) Weiss Amir (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/01/2024 7:03 AM | Phoenix Holdings Ltd. (Filed by) Teva Pharmaceutical Industries (Subject)
| Form SC 13G | |
02/01/2024 6:26 AM | Kalif Eliyahu Sharon (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/01/2024 6:28 AM | Daniell Richard (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/01/2024 6:18 AM | Sabag Mark (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/01/2024 6:22 AM | Drape Eric (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2024 6:00 AM | Teva Pharmaceutical Industries (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/22/2023 6:18 AM | Fox Christine (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/22/2023 6:17 AM | Fox Christine (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
11/16/2023 6:35 AM | Bergwerk Dov (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/16/2023 6:36 AM | Conway Vikki L (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/08/2023 6:01 AM | Teva Pharmaceutical Industries (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/18/2023 6:15 AM | Bergwerk Dov (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
10/05/2023 6:20 AM | Conway Vikki L (Reporting) Teva Pharmaceutical Industries (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
10/04/2023 5:05 AM | Teva Pharmaceutical Industries (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |